JP2024516610A5 - - Google Patents

Info

Publication number
JP2024516610A5
JP2024516610A5 JP2023564436A JP2023564436A JP2024516610A5 JP 2024516610 A5 JP2024516610 A5 JP 2024516610A5 JP 2023564436 A JP2023564436 A JP 2023564436A JP 2023564436 A JP2023564436 A JP 2023564436A JP 2024516610 A5 JP2024516610 A5 JP 2024516610A5
Authority
JP
Japan
Prior art keywords
polypeptide
mhc class
amino acid
acid substitution
tmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025552 external-priority patent/WO2022226073A1/en
Publication of JP2024516610A publication Critical patent/JP2024516610A/ja
Publication of JP2024516610A5 publication Critical patent/JP2024516610A5/ja
Pending legal-status Critical Current

Links

JP2023564436A 2021-04-21 2022-04-20 Mhcクラスii t細胞調節ポリペプチド及びその使用方法 Pending JP2024516610A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163177660P 2021-04-21 2021-04-21
US63/177,660 2021-04-21
PCT/US2022/025552 WO2022226073A1 (en) 2021-04-21 2022-04-20 Mhc class ii t-cell modulatory polypeptides and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024516610A JP2024516610A (ja) 2024-04-16
JP2024516610A5 true JP2024516610A5 (cg-RX-API-DMAC7.html) 2025-04-28

Family

ID=83723384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564436A Pending JP2024516610A (ja) 2021-04-21 2022-04-20 Mhcクラスii t細胞調節ポリペプチド及びその使用方法

Country Status (7)

Country Link
US (1) US20240139298A1 (cg-RX-API-DMAC7.html)
EP (1) EP4326337A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024516610A (cg-RX-API-DMAC7.html)
CN (1) CN117396229A (cg-RX-API-DMAC7.html)
AU (1) AU2022261910A1 (cg-RX-API-DMAC7.html)
CA (1) CA3212765A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022226073A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019051127A1 (en) 2017-09-07 2019-03-14 Cue Biopharma, Inc. MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004216925B2 (en) * 2003-03-07 2010-04-22 London Health Sciences Centre Research Inc. Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases
CN110396133B (zh) * 2018-04-25 2021-07-23 免疫靶向有限公司 一种以白介素12为活性成分的融合蛋白型药物前体
WO2020132366A2 (en) * 2018-12-19 2020-06-25 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof
EP3897690A4 (en) * 2018-12-19 2022-09-28 Cue Biopharma, Inc. T LYMPHOCYTE MODULATOR MULTIMERIC POLYPEPTIDES HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
WO2020132365A2 (en) * 2018-12-19 2020-06-25 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof
JP7691927B2 (ja) * 2019-03-06 2025-06-12 キュー バイオファーマ, インコーポレイテッド T細胞調節抗原提示ポリペプチド及びその使用方法
WO2020181062A1 (en) * 2019-03-06 2020-09-10 Cue Biopharma, Inc. T-cell modulatory multimeric polypeptides and methods of use thereof
WO2022226058A1 (en) * 2021-04-22 2022-10-27 Cue Biopharma, Inc. Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof

Similar Documents

Publication Publication Date Title
Clevers et al. The T cell receptor/CD3 complex: a dynamic protein ensemble
Gregor et al. Molecular structure of the chick cerebellar kainate-binding subunit of a putative glutamate receptor
Manolios et al. Pairwise, cooperative and inhibitory interactions describe the assembly and probable structure of the T‐cell antigen receptor.
JP2023527049A5 (cg-RX-API-DMAC7.html)
JP2022536581A5 (cg-RX-API-DMAC7.html)
Ikuta et al. Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins.
JP2021191265A5 (cg-RX-API-DMAC7.html)
GB2611448A (en) Polypeptide useful in adoptive cell therapy
JP2022515330A5 (cg-RX-API-DMAC7.html)
Rubin et al. The molecular basis for the generation of the human soluble interleukin 2 receptor
EP0379904B1 (en) A soluble molecule related to but distinct from ICAM-1
CN117986384A (zh) 与il-12和il-18的基于il-15的融合物
JPS61257998A (ja) ヘテロダイマ性tリンパ球レセプタ
Kinet The γ-ξ dimers of Fc receptors as connectors to signal transduction
JPH09121871A (ja) T細胞抗原レセプターα−サブユニット関連核酸及び抗体
WO1996018105A1 (en) Single chain t-cell receptor
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
JP2023526723A5 (cg-RX-API-DMAC7.html)
JP2022522405A5 (cg-RX-API-DMAC7.html)
CN111892661A (zh) 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用
US20080207485A1 (en) Mhc Oligomer And Method Of Making The Same
JP2023524132A5 (cg-RX-API-DMAC7.html)
WO2020259541A1 (zh) 一种用于肿瘤治疗的嵌合抗原受体t淋巴细胞及其制备方法与应用
JP2023541366A5 (cg-RX-API-DMAC7.html)
JP2022523024A5 (cg-RX-API-DMAC7.html)